Cargando…
High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
BACKGROUND: Hodgkin lymphoma (HL) patients have a good prognosis after adequate treatment. Previous treatment with mantle field irradiation has been accompanied by an increased long-term risk of cardiovascular disease (CVD). This study identified co-morbidity factors for the development of cardiovas...
Autores principales: | Andersson, Anne, Enblad, Gunilla, Erlanson, Martin, Johansson, Ann-Sofie, Molin, Daniel, Tavelin, Björn, Näslund, Ulf, Melin, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043572/ https://www.ncbi.nlm.nih.gov/pubmed/33889307 http://dx.doi.org/10.48101/ujms.v126.6117 |
Ejemplares similares
-
P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.
por: Linderoth, Johan, et al.
Publicado: (2022) -
Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
por: Hollander, Peter, et al.
Publicado: (2018) -
Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
por: Andersson, A, et al.
Publicado: (2008) -
P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients
por: Goldkuhl, Christina, et al.
Publicado: (2022) -
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
por: Övergaard, Ninja, et al.
Publicado: (2022)